Researchers have identified potential biomarkers for diabetic retinopathy, having demonstrated a link between increasing levels of MCP-1 and cathepsin-D with disease severity.
Researchers from the University of Missouri (MO, USA) have explored how protein testing could aid prostate cancer diagnosis and treatment.
Prospective clinical trial results demonstrate that a biomarker blood test could detect lung cancer recurrence on average 6 months earlier than CT scans.
Researchers from Flinders University (Adelaide, Australia) report the identification of a new urine biomarker – p75ECD – in amyotrophic lateral sclerosis patients.
Researchers identify a new biomarker that may improve diagnosis and treatment of individuals with pulmonary arterial hypertension.
In a recent study researchers describe the association between lower levels of BDNF with depression in pregnant women as well as low fetal birth weight.
Researchers have discovered a potential protein biomarker that may allow clinicians to decide whether patients with triple-negative breast cancer are likely to respond well to treatment with paclitaxel, and whether a cancer cell is likely to become chemoresistant.
View webinar on demand Early-stage biomarker assay development and validation plays an increasingly important role…